ANDREW DUDUM
Hims & Hers Health shares plunge 14% - here's what is fueling the fallHims stock: Hims & Hers Health shares saw a sharp decline on Friday. This happened after CEO Andrew Dudum sold shares worth approximately $...
Hims & Hers Q2 revenue drop shakes stock—Hims crashes 11% after first-ever revenue decline, is the weight-loss drug hype finally fading?Hims & Hers stock dropped a sharp 11% after the company missed Q2 2025 revenue estimates, raising concerns about its booming weight-loss dr...
Hims stock tanks over 20% after Wegovy deal collapse — why Novo Nordisk’s breakup over weight loss drugs is shaking up Wall StreetHims stock took a major hit after Novo Nordisk suddenly ended their Wegovy partnership, causing shares to drop over 20% in a single day. Th...
- Load More